CD44 and cancer: To assess this, a panel of representative genes considered as stemness markers (NANOG, OCT4, SOX2 and BMI1) or as specific cancer stem cell (CSC) markers (ABCG2, CD44 and ALDH1) [27] were analyzed by qRT-PCR.